AKBA · Akebia Therapeutics, Inc.

$0.87 +0.00 (+0.37%) At close · Aug 14

Market Cap

$241.86M

277.11M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2014-12-31	$162,000	—	—	10-K, filed 2017-03-06

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2014-12-31	$83,000 Δ	—	—	10-K, filed 2017-03-06
2014-09-30	$58,000 Δ	—	—	10-Q, filed 2015-11-09

Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 161 filings 161 filers Visit website Investor relations